216 related articles for article (PubMed ID: 8387801)
21. Treatment of postoperative Aspergillus fumigatus spondylodiscitis with itraconazole.
Peters-Christodoulou MN; de Beer FC; Bots GT; Ottenhoff TM; Thompson J; van 't Wout JW
Scand J Infect Dis; 1991; 23(3):373-6. PubMed ID: 1652789
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis of invasive aspergillosis by tracking Aspergillus-specific T cells in hematologic patients with pulmonary infiltrates.
Potenza L; Barozzi P; Vallerini D; Bosco R; Quadrelli C; Mediani L; Morselli M; Forghieri F; Volzone F; Codeluppi M; Rossi G; Tazzioli G; Venturelli C; Torelli G; Luppi M
Leukemia; 2007 Mar; 21(3):578-81. PubMed ID: 17215858
[No Abstract] [Full Text] [Related]
23. Paradoxical increase in circulating Aspergillus antigen during treatment with caspofungin in a patient with pulmonary aspergillosis.
Klont RR; Mennink-Kersten MA; Ruegebrink D; Rijs AJ; Blijlevens NM; Donnelly JP; Verweij PE
Clin Infect Dis; 2006 Aug; 43(3):e23-5. PubMed ID: 16804836
[TBL] [Abstract][Full Text] [Related]
24. Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. French Cooperative Study Group on Aspergillosis in AIDS.
Lortholary O; Meyohas MC; Dupont B; Cadranel J; Salmon-Ceron D; Peyramond D; Simonin D
Am J Med; 1993 Aug; 95(2):177-87. PubMed ID: 8395142
[TBL] [Abstract][Full Text] [Related]
25. Disseminated invasive aspergillosis in a patient with acute leukaemia.
Gottfredsson M; Steingrímsdóttir H
Acta Biomed; 2006; 77 Suppl 2():10-3. PubMed ID: 16918060
[TBL] [Abstract][Full Text] [Related]
26. Itraconazole treatment of pulmonary aspergillosis in leukaemia patients during a nosocomial epidemic associated with indoor building renovation.
Brincker H; Christensen BE; Schmidt KG; Hornstrup MK
Mycoses; 1991; 34(9-10):395-400. PubMed ID: 1668179
[TBL] [Abstract][Full Text] [Related]
27. Chronic necrotising pulmonary aspergillosis treated with itraconazole.
Elliott JA; Milne LJ; Cumming D
Thorax; 1989 Oct; 44(10):820-1. PubMed ID: 2556808
[TBL] [Abstract][Full Text] [Related]
28. Multidrug resistance in Aspergillus fumigatus.
Warris A; Weemaes CM; Verweij PE
N Engl J Med; 2002 Dec; 347(26):2173-4. PubMed ID: 12501236
[No Abstract] [Full Text] [Related]
29. Intravenous itraconazole for treating invasive pulmonary aspergillosis in neutropenic patients with acute lymphoblastic leukemia.
Picardi M; Camera A; Luciano L; Ciancia R; Rotoli B
Haematologica; 2003 Feb; 88(2):ELT01. PubMed ID: 12604432
[No Abstract] [Full Text] [Related]
30. [Invasive pulmonary aspergillosis caused by Aspergillus ochraceus].
Wierzbicka M; Podsiadło B; Janczarski M
Pneumonol Alergol Pol; 1997; 65(3-4):254-60. PubMed ID: 9489424
[TBL] [Abstract][Full Text] [Related]
31. Itraconazole and aspergilloma.
Ruffin RE
Eur Respir J; 1991 Apr; 4(4):511. PubMed ID: 1649769
[No Abstract] [Full Text] [Related]
32. Comparison of azoles against aspergilli in vitro and in an experimental model of pulmonary aspergillosis.
Schmitt HJ; Edwards F; Andrade J; Niki Y; Armstrong D
Chemotherapy; 1992; 38(2):118-26. PubMed ID: 1317280
[TBL] [Abstract][Full Text] [Related]
33. Itraconazole, a new triazole that is orally active in aspergillosis.
Van Cutsem J; Van Gerven F; Van de Ven MA; Borgers M; Janssen PA
Antimicrob Agents Chemother; 1984 Oct; 26(4):527-34. PubMed ID: 6097167
[TBL] [Abstract][Full Text] [Related]
34. Aspergillus osteoarthritis in acute lymphoblastic leukemia.
Gunsilius E; Lass-Flörl C; Mur E; Gabl C; Gastl G; Petzer AL
Ann Hematol; 1999 Nov; 78(11):529-30. PubMed ID: 10602898
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice.
Troke PF; Andrews RJ; Marriott MS; Richardson K
J Antimicrob Chemother; 1987 May; 19(5):663-70. PubMed ID: 3038824
[TBL] [Abstract][Full Text] [Related]
36. Combined anti-fungal therapy and surgical resection as treatment of disseminated aspergillosis of the lung and brain following BMT.
Trigg ME; Menezes AH; Giller R; Lanza L; Smith RJ; Sato Y; Peters C; Altman A
Bone Marrow Transplant; 1993 Jun; 11(6):493-6. PubMed ID: 8392887
[TBL] [Abstract][Full Text] [Related]
37. Cerebral and pulmonary aspergillosis, treatment and diagnostic challenges of mixed breakthrough invasive fungal infections: case report study.
Amanati A; Lotfi M; Masoudi MS; Jafarian H; Ghasemi F; Bozorgi H; Badiee P
BMC Infect Dis; 2020 Jul; 20(1):535. PubMed ID: 32703183
[TBL] [Abstract][Full Text] [Related]
38. Early experience with itraconazole in vitro and in patients: pharmacokinetic studies and clinical results.
Dupont B; Drouhet E
Rev Infect Dis; 1987; 9 Suppl 1():S71-6. PubMed ID: 3027850
[TBL] [Abstract][Full Text] [Related]
39. A comparison of the efficacy of itraconazole, amphotericin B and 5-fluorocytosine in the treatment of Aspergillus fumigatus endocarditis in the rabbit.
Longman LP; Martin MV
J Antimicrob Chemother; 1987 Nov; 20(5):719-24. PubMed ID: 2828301
[TBL] [Abstract][Full Text] [Related]
40. Disseminated invasive aspergillosis in an apparently immunocompetent host.
Raja NS; Singh NN
J Microbiol Immunol Infect; 2006 Feb; 39(1):73-7. PubMed ID: 16440127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
